Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

TEPADINA AND SODIUM CHLORIDE

THIOTEPA

Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview TEPADINA AND SODIUM CHLORIDE is listed in Drugs@FDA under application 208264 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient THIOTEPA Form and strength POWDER;INTRAVENOUS - 400MG Sponsor ADIENNE SA Submission history Latest submission status date: 2026-01-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview TEPADINA AND SODIUM CHLORIDE is listed in Drugs@FDA under application 208264 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient THIOTEPA Form and strength POWDER;INTRAVENOUS - 400MG Sponsor ADIENNE SA Submission history Latest submission status date: 2026-01-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.